Inventor · disambiguated record
Bruno Domon
Also filed as: DOMON BRUNO
19 granted patents·27 pending applications·393 citations·filing 2003–2023
94Inventor score
Files withCELERA CORP20APPLERA CORP10DOMON BRUNO4FUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA3LOUETTE JOEL2
Top patents by PatentIndex Score
46 records- 0197US7582441B1Methods and compositions for treating and diagnosing diseaseCELERA CORP·Filed 2006·Granted Sep 1, 2009·26 cites·3 claims
- 0296US7473531B1Pancreatic cancer targets and uses thereofCELERA CORP·Filed 2004·Granted Jan 6, 2009·141 cites·3 claims
- 0395US7807392B1Lung disease targets and uses thereofCELERA CORP·Filed 2007·Granted Oct 5, 2010·74 cites·5 claims
- 0495US7358231B1Pancreatic cancer secreted targets and uses thereofAPPLERA CORP·Filed 2006·Granted Apr 15, 2008·111 cites·15 claims
- 0591US8334106B2Methods and compositions for treating and diagnosing diseasesRUBEN STEVE·Filed 2011·Granted Dec 18, 2012·7 cites·5 claims
- 0690US8632987B2Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2012·Granted Jan 21, 2014·5 cites·5 claims
- 0790US8110373B2Methods and compositions for treating and diagnosing diseasesRUBEN STEVE·Filed 2009·Granted Feb 7, 2012·7 cites·5 claims
- 0887US9377469B2Analyte mass spectrometry quantitation using a universal reporterLOUETTE JOEL·Filed 2014·Granted Jun 28, 2016·6 cites·19 claims
- 0987US8933396B2Analyte mass spectrometry quantitation using a universal reporterLOUETTE JOEL·Filed 2011·Granted Jan 13, 2015·8 cites·5 claims
- 1083US7960100B1Colon cancer targets and uses thereofCELERA CORP·Filed 2008·Granted Jun 14, 2011·4 cites·3 claims
- 1181US9090682B2Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2013·Granted Jul 28, 2015·3 cites·8 claims
- 1275US9658232B2Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2015·Granted May 23, 2017·1 cites·6 claims
- 1372US2020325189A1Colon disease targets and uses thereofCELERA CORP·Filed 2020·Application pending·0 cites
- 1470US2020276329A1Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2020·Application pending·0 cites
- 1570US2020116726A1Pancreatic cancer targets and uses thereofCELERA CORP·Filed 2019·Application pending·0 cites
- 1667US2015132286A1Pancreatic cancer targets and uses thereofCELERA CORP·Filed 2014·Application pending·0 cites
- 1767US2009138977A1Pancreatic cancer targets and uses thereofCELERA CORP·Filed 2008·Application pending·0 cites
- 1867US2018251502A1Colon disease targets and uses thereofCELERA CORP·Filed 2017·Application pending·0 cites
- 1966US2014178391A1Colon disease targets and uses thereofCELERA CORP·Filed 2013·Application pending·0 cites
- 2066US2017350897A1Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2017·Application pending·0 cites
- 2164US2024011994A1Ctnb1 as a marker for endometrial cancerFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2023·Application pending·0 cites
- 2263US7348416B2Selective capture and enrichment of proteins expressed on the cell surfaceAPPLERA CORP·Filed 2004·Granted Mar 25, 2008·0 cites·7 claims
- 2362US2023221323A1Markers of endometrial cancerFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2022·Application pending·0 cites
- 2460US2016137705A1Colon disease targets and uses thereofCELERA CORP·Filed 2015·Application pending·0 cites
- 2558US2017219591A1Pancreatic cancer targets and uses thereofCELERA CORP·Filed 2016·Application pending·0 cites
- 2657US9945867B2Analyte mass spectrometry quantitation using a universal reporterTHERMO FISHER SCIENT GMBH·Filed 2015·Granted Apr 17, 2018·0 cites·4 claims
- 2756US2013067608A1Colon cancer targets and uses thereofDOMON BRUNO·Filed 2012·Application pending·0 cites
- 2856US2009196873A1Methods and compositions for treating diseases targeting CDCP1APPLERA CORP·Filed 2008·Application pending·0 cites
- 2956US2014178362A1Methods and compositions for treating diseases targeting mabaCELERA CORP·Filed 2013·Application pending·0 cites
- 3055US2008219992A1Pancreatic cancer secreted targets and uses thereofAPPLERA CORP·Filed 2008·Application pending·0 cites
- 3155US2008076907A1Selective capture and enrichment of proteins expressed on the cell surfaceAPPLERA CORP·Filed 2007·Application pending·0 cites
- 3253US8865413B2Pancreatic cancer targets and uses thereofDOMON BRUNO·Filed 2011·Granted Oct 21, 2014·0 cites·3 claims
- 3352US7776555B1Colon disease targets and uses thereofCELERA CORP·Filed 2007·Granted Aug 17, 2010·0 cites·3 claims
- 3452US2007031419A1Methods and compositions for treating diseases targeting CDCP1APPLERA CORP·Filed 2006·Application pending·0 cites
- 3551US2011296544A1Colon cancer targets and uses thereofDOMON BRUNO·Filed 2011·Application pending·0 cites
- 3650US2006029988A1Method and compositions for treating diseases targeting E-cadherinAPPLERA CORP·Filed 2004·Application pending·0 cites
- 3748US8507213B1Methods and compositions for treating diseases targeting mabaLEE CANDY·Filed 2006·Granted Aug 13, 2013·0 cites·3 claims
- 3846US2006029987A1Diagnosis of pancreatic cancer by using pancreatic targetsAPPLERA CORP·Filed 2004·Application pending·0 cites
- 3946US2006039907A1Method and compositions for treating diseases targeting CD71APPLERA CORP·Filed 2004·Application pending·0 cites
- 4046US2006035239A1Method and compositions for treating diseases targeting CD51APPLERA CORP·Filed 2004·Application pending·0 cites
- 4145US2007059757A1Method and compositions for the treating diseases targeting E-cadherinDOMON BRUNO·Filed 2006·Application pending·0 cites
- 4245US2019137499A1Markers of Endometrial CancerFUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA·Filed 2017·Application pending·0 cites
- 4345US2020264183A1Ctnb1 as a marker for endometrial cancerFUNDACIO HOSPITAL UNIV VALL D'HEBRON - INSTITUT DE RECERCA·Filed 2018·Application pending·0 cites
- 4443US2011219464A1Lung disease targets and uses thereofCELERA CORP·Filed 2010·Application pending·0 cites
- 4542US7604931B2Cripto mutant and uses thereofBIOGEN IDEC INC·Filed 2003·Granted Oct 20, 2009·0 cites·7 claims
- 4620US11536724B2Bladder cancer biomarker proteinsPOLYQUANT GMBH·Filed 2016·Granted Dec 27, 2022·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Bruno Domon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →